Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 320,707,173
- Total 13F value
- $8,183,523,072
- Share change
- +6,055,853
- Put/Call ratio
- 23%
- SEC-reported price per share
- $25.51
- Number of holders
- 414
- Value change
- +$144,649,409
- Number of buys
- 214
- Number of sells
- 185
- Shares outstanding
- 445,144,313
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
414
Top holders
10
RPRX full security history
Ownership snapshot
Full 13F holder table
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Ownership snapshot
Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 5.7%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
5.7%
MORGAN STANLEY
9.2%
VANGUARD GROUP INC
8.4%
FMR LLC
6.3%
BAILLIE GIFFORD & CO
3.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
5.7%
|
$832,319,492
25,445,414 shares
|
$0 | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
9.2%
|
$1,162,101,308
41,078,163 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
8.4%
|
$1,063,283,130
37,585,123 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
6.3%
|
$789,012,140
27,890,143 shares
|
— | 30 Sep 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
3.6%
|
$456,105,271
16,122,491 shares
|
— | 30 Sep 2024 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
2.7%
|
$342,139,854
12,094,021 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
414
Shares
320,707,173
Rows available
414
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
391
Q4 2024 holders
414
Holder diff
23
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|